Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Andres Trelles"'
Autor:
Díaz-Caneja, CM, State, MW, Hagerman, RJ, Jacquemont, S, Marín, O, Bagni, C, Umbricht, D, Simonoff, E, de Andrés-Trelles, F, Kaale, A, Pandina, G, Gómez-Mancilla, B, Wang, PP, Cusak, J, Siafis, S, Leucht, S, Parellada, M, Loth, E, Charman, T, Buitelaar, JK, Murphy, D, Arango, C
Publikováno v:
In European Neuropsychopharmacology July 2021 48:49-88
Autor:
de Andres-Trelles, F.
Publikováno v:
In European Neuropsychopharmacology July 2015 25(7):1039-1044
Autor:
Charlotte Maserumule, Charlotte Passemar, Olivia S H Oh, Kriztina Hegyi, Karen Brown, Aaron Weimann, Adam Dinan, Sonia Davila, Catherine Klapholz, Josephine Bryant, Deepshikha Verma, Jacob Gadwa, Shivankari Krishnananthasivam, Kridakorn Vongtongsalee, Edward Kendall, Andres Trelles, Martin L Hibberd, Rafael Prados-Rosales, Kaliappan Andi, S Siva Kumar, Diane Ordway, Paul A MacAry, R. Andres Floto
Genetic determinants of susceptibility to Mycobacterium tuberculosis (Mtb) are poorly understood but could provide insights into critical pathways involved in infection, informing host-directed therapies and enabling risk stratification at individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::643167ebe1031973e35fb3e3b0e6017d
https://doi.org/10.1101/2022.06.14.496072
https://doi.org/10.1101/2022.06.14.496072
Autor:
Anett Kaale, Tony Charman, Covadonga M. Díaz-Caneja, Claudia Bagni, Matthew W. State, Stefan Leucht, Declan G. Murphy, F. de Andres-Trelles, Spyridon Siafis, Jan K. Buitelaar, Oscar Marín, Emily Simonoff, C. Arango, Daniel Umbricht, J Cusak, Randi J Hagerman, Gahan Pandina, M. Parellada, Sébastien Jacquemont, Eva Loth, P P Wang, Baltazar Gomez-Mancilla
Publikováno v:
European Neuropsychopharmacology, 48, pp. 49-88
European Neuropsychopharmacology, 48, 49-88
European Neuropsychopharmacology, 48, 49-88
Contains fulltext : 235396.pdf (Publisher’s version ) (Open Access) In the last decade there has been a revolution in terms of genetic findings in neurodevelopmental disorders (NDDs), with many discoveries critical for understanding their aetiology
Autor:
Gispen-de Wied, Christine, Stoyanova, Violeta, Yu, Yang, Isaac, Maria, Pani, Luca, de Andres-Trelles, Fernando
Publikováno v:
In European Neuropsychopharmacology November 2012 22(11):804-811
Autor:
Dimitrios Athanasiou, Marion Haberkamp, Armando Magrelli, Jane Moseley, Fernando de Andres-Trelles, Andre Elferink, Mário M. Rosa
Publikováno v:
Neuromuscular Disorders. 29:514-516
Development of novel therapies for Duchenne muscular dystrophy (DMD) are driving the need for more efficient ways of detecting changes in disease- progression in DMD [1]. However, medicines' approval must be based on outcome measures that are accepta
Autor:
Sanz Nuria, Schieppati Arrigo, Gaynor Siobhan, O'Brien Timothy, Cooney Margaret, Kardos Gabriella, Blasko Gyorgy, Temesvari Zsuzsa, Grychtol Ruth, Dreier Gabriele, Grählert Xina, Barraud Béatrice, Libersa Christian, Whitfield Kate, Thirstrup Steffen, Huemer Karl-Heinz, Kuchinke Wolfgang, de Andres-Trelles Fernando, Kubiak Christine, Hernandez Raquel, Asker-Hagelberg Charlotte, Johansson Hanna, Bourne Sue, Byrne Jane, Asghar Adeeba, Husson Jean-Marc, Gluud Christian, Demotes-Mainard Jacques
Publikováno v:
Trials, Vol 10, Iss 1, p 95 (2009)
Abstract Background Thorough knowledge of the regulatory requirements is a challenging prerequisite for conducting multinational clinical studies in Europe given their complexity and heterogeneity in regulation and perception across the EU member sta
Externí odkaz:
https://doaj.org/article/76509724b68547a6a7ca1083a8f1ce93
Autor:
F. de Andres-Trelles
Publikováno v:
European Neuropsychopharmacology. 25:1039-1044
Since medicines for psychiatric diseases are often studied in adults first, it would be useful if data from efficacy trials in adults could be extrapolated to children and adolescents. However, it is not sufficient to adapt the adult dosages to achie
Autor:
F. de Andres-Trelles, N. Laguna-Goya
Publikováno v:
European Journal of Clinical Pharmacology. 70:519-525
To analyse publically available official reports on the evaluation of European Union (EU) registration of new medicines (aimed at diseases affecting both sexes) in order to address the possibility of gender bias. Descriptive study reviewing two types
Autor:
Ferrán Catalá-López, Diego Macías Saint-Gerons, César de la Fuente Honrubia, Fernando de Andres-Trelles
Publikováno v:
Medicina Clínica. 144:285-287